Nagy A Habib
Imperial College London
Nagy Habib, Professor of Hepatobiliary Surgery at Imperial College London is a translational researcher who pioneered the first clinical trial in the use of adenovirus and plasmid for the treatment of liver cancer, and the use of plasmid gene therapy in hydrodynamic gene delivery. He was also the first to publish from the West a clinical trial on the use of adult bone marrow-derived stem cells for the treatment of patients with liver insufficiency. He has published on the evolution of molecular biology of tumours (oncogene, tumour suppressor gene, epigenetic modification), gene therapy, stem cell therapy, saRNA and RNAaptamers.
liver cancer and its treatment, tumors from oncogene, tumor suppressor gene, epigenetic modification, genetherapy, stem cell therapy, RNA (Ribonucleic acid) and saRNA (small activating RNA) and RNA aptamers.